LONZA N/ CH0013841017 /
| 7/26/2024 5:30:46 PM | Chg. +21.20 | Volume | Bid8:46:58 PM | Ask8:46:58 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 581.00CHF | +3.79% | 271,132 Turnover: 156.36 mill. |
-Bid Size: 25 | -Ask Size: 25 | 43.27 bill.CHF | 0.69% | 65.43 |
GlobeNewswire
6/14
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at...
GlobeNewswire
5/30
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively licens...
GlobeNewswire
5/15
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ dec...
GlobeNewswire
4/4
Galapagos showcases innovative approach in hematological cancer care with clinical and translational...
GlobeNewswire
4/4
Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire
2/27
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire
1/4
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further exp...
GlobeNewswire
12/19/2023
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufacture...
GlobeNewswire
12/9/2023
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire
12/7/2023
Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...
GlobeNewswire
11/6/2023
Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
10/16/2023
Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire
10/2/2023
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire
9/20/2023
Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
